Background: The COVID-19 vaccines raised hopes of returning to normalcy; however, their
acceptability remains contested and has never been evaluated in an international study from …

Objectives The aim of the present work was to explore the perspectives of Egyptian
Rheumatology staff members as regards the coronavirus disease-19 (COVID-19) vaccine …

This study aims to investigated COVID‐19 vaccine acceptance among people with chronic
diseases and the factors correlating with their vaccination hesitancy. The articles were …

Background COVID-19 booster dose vaccination acceptance and actual vaccination
behavior is not known among Egyptian individuals with autoimmune and rheumatic …

Background: Coronavirus disease 2019 (covid-19) has now spread to millions of persons
worldwide to become a global pandemic. Covid-19 is asymptomatic for some individuals …

Objectives Vaccination against COVID-19 emerges as an effective strategy for combating
the pandemic. While many of our patients with rheumatic diseases (RD) wonder whether it is …

Background Safety and efficacy of severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2) vaccine among systemic rheumatic diseases (SRDs) remain a serious concern. Aim …

Similarly to the general population, advanced age, comorbidities and chronic glucocorticoid
treatment (≥ 10 mg/day prednisoneequivalent) have been identified as negative prognostic …

Patients with chronic rheumatic diseases are a particularly susceptible population affected
by the COVID-19 pandemic, 1, 2 and their protection through vaccination was prioritised …

The attitudes toward emerging COVID-19 vaccines have been of great interest worldwide,
especially among vulnerable populations such as patients with rheumatic and …